Related Experiment Video
Updated: Jul 18, 2026
04:59
Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
Published on: July 7, 2023
Posterior capsule opacification after combined cataract surgery and vitrectomy
Junko Toda1, Satoshi Kato, Tetsuro Oshika
1Department of Ophthalmology, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan.
Journal of Cataract and Refractive Surgery
|December 27, 2006
Summary
Combined cataract and vitrectomy surgery increases posterior capsule opacification (PCO) risk, especially in patients with diabetes mellitus (DM). Careful monitoring for PCO is crucial after combined procedures, even in non-diabetic patients.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Diabetic Retinopathy
Background:
- Posterior capsule opacification (PCO) is a common complication after cataract surgery.
- The impact of combined cataract surgery and vitrectomy on PCO, particularly in diabetic patients, requires further investigation.
Purpose of the Study:
- To compare PCO development after combined cataract surgery and vitrectomy versus cataract surgery alone.
- To assess the influence of diabetes mellitus (DM) on PCO rates in both surgical groups.
Main Methods:
- Prospective study comparing cataract surgery alone versus combined cataract and vitrectomy.
- Patients categorized into diabetic (DM) and non-diabetic (non-DM) subgroups.
- PCO rates assessed using the POCO system at 3, 6, and 12 months postoperatively.
Main Results:
- In the cataract-only group, PCO rates were significantly higher in the DM subgroup than the non-DM subgroup.
- Combined surgery led to significantly higher PCO rates than cataract surgery alone in the non-DM subgroup.
- No significant difference in PCO rates between DM and non-DM subgroups within the combined surgery group.
Conclusions:
- Combined cataract and vitrectomy surgery is associated with increased PCO development.
- Diabetes mellitus does not significantly alter PCO rates after combined surgery.
- Close monitoring for PCO is essential for all patients undergoing combined cataract and vitrectomy, irrespective of DM status.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...